Skip to main content
Log in

Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins

  • Cancer
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

There are numerous growing evidences of resemblance between carcinomas of the breast and prostate. A total of 45 cases of these two hormone-dependent cancers along with appropriate controls were subjected for status of epidermal growth factor receptors as well as serum lipid profile. Paraffin embedded tissue sections from aforesald tumours were analysed by immunohistochemical staining for epidermal growth factor receptor (EGF-R), c-erbB-2 oncoprotein, estrogen receptor (ER) and progesterone receptor (PgR). Sera from same individuals were studied for serum lipid profile analysis. The study revealed that immunoexpression of all receptor proteins (EGF-R). c-erbB-2 was significantly higher in breast carcinoma. In addition, mean levels of triglycerides, total cholesterol, LDL-cholesterol were found to be significantly elevated while the level of HDL-cholesterol was observed to be lower among patients with breast cancer as compared to matched controls. Further, ER-positive breast cancer cases have significantly higher mean level of HDL-cholesterol when compared with ER-negative breast cancer patients. Contrary to this, no alteration in different serum lipid fractions was noticed among the patients with prostate cancer. However, a positive relationship was noticed between immunoexpressions of EGF-R and c-erbB-2 in prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Du Pont, W.D. and Page, D.L. (1985) Risk factors for breast cancer in women with proliferative breast disease. New Engl. J. Med. 312, 146–151.

    Article  Google Scholar 

  2. Bernstein, L. and Ross, R.K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15, 48–65.

    PubMed  CAS  Google Scholar 

  3. Hulka, B.S. and Stark, A.T. (1995) Breast cancer: cause and prevention. Lancet 346, 883–887.

    Article  PubMed  CAS  Google Scholar 

  4. Persky, V.W., Chatterton, R.T., Van Hom, L.V., Grant, M.D., Langenberg, P. and Marvin, J. (1992) Hormone levels in vegetarian and nonvegetarian teenage girls: potential implications for breast cancer risk. Cancer Res. 52, 578–583.

    PubMed  CAS  Google Scholar 

  5. Knapp, M.L., Al-Sheibani, S. and Riches, P.G. (1991) Alterations of serum lipids in breast cancer: effects of disease activity, treatment and hormonal factors. Clin. Chem. 37, 2093–2101.

    PubMed  CAS  Google Scholar 

  6. Boyd, N.F., Connelly, P., Lynch, H., Knaus, M., Michal, S., Fili, M., Martin, L.J., Lockwood, G. and Tritchler, D. (1995) Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol. Biomarkers Prev. 4, 117–122.

    PubMed  CAS  Google Scholar 

  7. Bahadur, A.K., Yadav, R., Ray, A., Pasha, S.T., Sharma, S. and Sharma, B.K. (1998) Alteration in serum lipids and host cell mediated immune response in patients of carcinoma breast before, during and after treatment. J. Basic Appl. Biomed. 6, 19–24.

    Google Scholar 

  8. Fishman, J., Osborne, M.P. and Telang, N.T. (1995) The role of estrogen in mammary carcinogenesis. Ann. N. Y. Acad. Sci. 768, 91–100.

    Article  PubMed  CAS  Google Scholar 

  9. De Bortoli, M., Maggiora, P., Capello, D., Antoniotti, S., Saviozzi, S., Sapei, M.L. and Dati, C. (1996) Hormonal control of growth factor receptor expression. Ann. N. Y. Acad. Sci. 784, 336–348.

    Article  PubMed  Google Scholar 

  10. Sharma, B.K., Ray, A., Kaur, S. and Gupta, S. (1999) Immunohistochemical co-expression of c-erbB-2/New oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast. Indian J. Exp. Biol. 37, 223–227.

    PubMed  CAS  Google Scholar 

  11. Fox, S.B., Persad, R.A., Coleman, N., Day, C.A., Silcocks, P.B. and Collins, C.C. (1994) Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) protatic adenocarcinoma. Br. J. Urol. 74, 214–220.

    Article  PubMed  CAS  Google Scholar 

  12. Kukuho, M., Yoshiki, T., Hamagucha, A., Okada, Y., Tomoyoshi, T. and Higuchi, K. (1993) Immunohistochemical study of c-erbB-2 proto-oncogene product in prostate cancer. Jpn. J. Urol. 84, 1872–1878.

    Google Scholar 

  13. Ries, L.A.G., Hankey, B.D. and Edwards, B.K. (1990) Cancer statistics review 1973–87. N.I.H. Publ. 90, 2789.

    Google Scholar 

  14. Le Marchand, L., Kolonel, L.N. and Wilkens, L.R. (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiol. 5, 276–282.

    Article  Google Scholar 

  15. Ratnakar, N., Sharma, B.K., Chaturvedi, K.U., Kaur, S., Naik, S.L.D. and Ray, A. (1998) Immunohistochemical expression of c-erbB-2 oncoprotein and EGF-R in pre-and postmenopausal breast cancer. A.P.M.I.S. 106, 1075–1080.

    CAS  Google Scholar 

  16. Allan, C.C., Poon, L.S., Chan, C.G.S., Richmond, W. and Fu, P.C. (1974) Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470–475.

    Google Scholar 

  17. Wahlefield, A.W. (1974) Triglycerides: determination after enzymatic hydrolysis. In, Methods of enzymatic analysis, Vol II (Ed. Bergmeyer H.). Academic Press, New York, p. 1831.

    Google Scholar 

  18. Lopes-Virella, M.F., Stone, P., Ellis, S. and Colwell, J.A. (1977) Cholesterol determinations in highdensity lipoproteins separated by three different methods. Clin. Chem. 23, 882–884.

    PubMed  CAS  Google Scholar 

  19. Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.

    PubMed  CAS  Google Scholar 

  20. Peles, E. and Yarden, Y. (1993) Neu and its ligands: from an oncogene to neural factors. Bio. Essays 15, 815–824.

    CAS  Google Scholar 

  21. Lipponen, H.J., Aaltomaa, S., Syrjanen, S. and Syrjanen, K. (1993) c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Anticancer Res. 13, 1147–1152.

    PubMed  CAS  Google Scholar 

  22. Ioachim, E., Kamina, S., Athanassiadou, S. and Agnahtis, N.J. (1996) The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Anticancer Res. 16, 3141–3147.

    PubMed  CAS  Google Scholar 

  23. Koutselini, H., Markopoulos, C., Lambroupoulou, S., Gogas, H., Kandaraki, C. and Gogas, J. (1995) Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cnacer patients. Cytopathol. 6, 14–21.

    Article  CAS  Google Scholar 

  24. Wiltschke, C., Kindas-Muegge, J., Steininger, A., Reiner, A., Reiner, G. and Preis, P.N. (1994) Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients. J. Cancer Res. Clin. Oncol. 120, 737–742.

    Article  PubMed  CAS  Google Scholar 

  25. Rudas, M., Neumayer, R., Gnant, M.F., Mittelbock, M., Jakesz, R. and Reiner, A. (1997) p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur. J. Cancer 33, 39–44.

    Article  PubMed  CAS  Google Scholar 

  26. Hiatt, A., Friedman, G.D., Bawol, R.D. and Ury, H.K. (1982) Breast cancer and serum cholesterol. J. Natl. Cancer Inst. 68, 885–889.

    PubMed  CAS  Google Scholar 

  27. Agurs-Collins, T., Kim, K.S., Dunston, G.M. and Adams, C.L.L. (1998) Plasma lipid alterations in African-American women with breast cancers. J. Cancer Res. Clin. Oncol. 124, 186–190.

    Article  PubMed  CAS  Google Scholar 

  28. Qi, X.Y., Zhang, A.Y., Wu, G.L. and Pang, W.Z. (1994) The association between breast cancer and diet and other factors. Asia Pacific J. Public Health 7, 98–104.

    CAS  Google Scholar 

  29. Goodwin, P.J., Boyd, N.F., Hanna, W., Hartwick, W., Murray, D., Qizilbash, A., Redwood, S., Hood, N., Delgiudice, M.E., Sidlofsky, S., Mc Cready, D., Wilkinson, R., Mahoney, L., Connelly, P. and Page, D.L. (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr. Cancer 27, 284–292.

    Article  PubMed  CAS  Google Scholar 

  30. Takatani, O., Okumoto, T. and Kosano, H. (1991) Genesis of breast cancer in Japanese: a possible relationship between sex hormone binding globulin (SHBG) and serum lipid components. Breast Cancer Res. Treat. 18 (Suppl 1), S 27–29.

    Article  Google Scholar 

  31. Hoyer, A.P. and Engholm, G. (1992) Serum lipids and breast cancer risk: a cohort study of 5207 Danish women. Cancer Causes Control 3, 403–408.

    Article  PubMed  CAS  Google Scholar 

  32. Maygarden, S., Strom, S. and Ware, J. (1992) Localization of EGFR by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia and benign hyperplasia. Arch. Pathol. Lab. Med. 116, 269–273.

    PubMed  CAS  Google Scholar 

  33. Ibrahim, G., Kerri, B., Mac Donald, J., Ibrahim, S., Kinney, R., Humphrey, P. and Robertson, C. (1993) Different immunoreactivity of EGFR in benign, dysplastic and malignant prostate tissue. J. Urol. 149, 170–173

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, D., Ray, A., Bahadur, A.K. et al. Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins. Indian J Clin Biochem 16, 42–51 (2001). https://doi.org/10.1007/BF02867567

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02867567

Key words

Navigation